Pancreatic Cancer Research

ResearcherMichael E. DeBakey VA Medical CenterActive in the last 2 years

Changyi Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-1718-4717; OpenAlex author ID A5108098298. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2011: 5 papers · 2012: none · 2013: 4 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 13

  1. Mesothelin-Associated Anti-Senescence Through P53 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17122058↗
  2. A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma. Co-author DOI 10.1126/scitranslmed.abc3196↗
  3. Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib. Co-author DOI 10.1371/journal.pone.0213294↗
  4. Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival. Co-author DOI 10.18632/oncotarget.13704↗
  5. A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. Co-author DOI 10.1002/emmm.201302507↗
  6. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-12-3776↗
  7. Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine. Co-author DOI 10.12659/msm.889636↗
  8. Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS-… Co-author DOI 10.1371/journal.pone.0068303↗
  9. PDX-1: demonstration of oncogenic properties in pancreatic cancer. Co-author DOI 10.1002/cncr.25629↗
  10. Roles and mechanisms of microRNAs in pancreatic cancer. Last author DOI 10.1007/s00268-010-0952-z↗
  11. Chimeric Trop2 virus-like particles: a potential immunotherapeutic approach against pancreatic cancer. Co-author DOI 10.1097/cji.0b013e318209ee72↗
  12. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression. Co-author DOI 10.1186/1476-4598-10-106↗
  13. Overcoming drug resistance in pancreatic cancer. Co-author DOI 10.1517/14728222.2011.566216↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qizhi Cathy Yao · 11 shared papers, 2011–2025 · strength 0.87
  2. Dongliang Liu · 3 shared papers, 2019–2025 · strength 0.58
  3. Ethan C. Poteet · 2 shared papers, 2016–2019 · strength 0.17
  4. George Van Buren · 2 shared papers, 2016–2019 · strength 0.17
  5. Vanaja Konduri · 1 shared paper, 2021 · strength 0.10
  6. William Karl Decker · 1 shared paper, 2021 · strength 0.10
  7. Lin-Kin Yong · 2 shared papers, 2013–2016 · strength 0.10
  8. Min Li · 3 shared papers, 2011 · strength 0.09
  9. Rafael A. Cubas · 2 shared papers, 2011–2013 · strength 0.08
  10. Sheng Zhang · 2 shared papers, 2011–2013 · strength 0.08
  11. Christian Marín‐Müller · 2 shared papers, 2011–2013 · strength 0.07
  12. Uddalak Bharadwaj · 2 shared papers, 2011–2013 · strength 0.07
  13. William E. Fisher · 2 shared papers, 2013 · strength 0.06
  14. Jingxuan Yang · 2 shared papers, 2011–2013 · strength 0.06
  15. Xianjun Yu · 2 shared papers, 2011–2013 · strength 0.06
  16. Francis Charles Brunicardi · 2 shared papers, 2011–2013 · strength 0.05
  17. Min Li · 1 shared paper, 2013 · strength 0.03
  18. Mien‐Chie Hung · 1 shared paper, 2013 · strength 0.03
  19. Lidong Zhang · 1 shared paper, 2011 · strength 0.03
  20. Yu‐Qing Zhang · 1 shared paper, 2013 · strength 0.03
  21. Huamin Wang · 1 shared paper, 2013 · strength 0.03
  22. Min Li · 1 shared paper, 2013 · strength 0.03
  23. Xiaobo Cui · 1 shared paper, 2013 · strength 0.03
  24. Yong Chen · 1 shared paper, 2013 · strength 0.03
  25. Paul J. Chiao · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.